Travelers With Immune‐Mediated Inflammatory Diseases: Are They Different?
ConclusionsThe increasing numbers of IMID patients, many using immunosuppressive or immunomodulatory therapy, show similar travel patterns as non‐IMID travelers. Thus, they are exposed to the same travel health risks, vaccine‐preventable infections being one among them. Particularly, in view of the fact that live attenuated vaccines are less often administered to IMID patients more data are needed on the safety and immunogenicity of vaccines and on travel‐specific risks to be able to offer evidence‐based pre‐travel health advice. (Source: Journal of Travel Medicine)
Source: Journal of Travel Medicine - November 1, 2014 Category: Infectious Diseases Authors: Veronika K. Jaeger, Rolanda Rüegg, Robert Steffen, Christoph Hatz, Silja Bühler Tags: ORIGINAL ARTICLE Source Type: research
Immunogenicity and Safety of Concomitant Administration of a Combined Hepatitis A/B Vaccine and a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults
ConclusionsMenACWY‐CRM can be administered concomitantly with a hepatitis A and/or B vaccine in the context of an accelerated hepatitis A and/or B immunization schedule without increasing safety concerns or compromising the immune responses to any of the vaccine antigens. [NCT01453348] (Source: Journal of Travel Medicine)
Source: Journal of Travel Medicine - November 1, 2014 Category: Infectious Diseases Authors: Martin Alberer, Gerd Burchard, Tomas Jelinek, Emil C. Reisinger, Seetha Meyer, Eduardo Forleo‐Neto, Alemnew F. Dagnew, Ashwani Kumar Arora Tags: ORIGINAL ARTICLE Source Type: research
Effectiveness of the Typhoid Vi Vaccine in Overseas Travelers from England
ConclusionsThe vaccine has been demonstrated to have a similar effectiveness in travelers as that found in endemic populations. It appears to be protective in all ages, including in young children (aged 2–5 years), a finding not consistently replicated in other studies. However, good hygiene practices are necessary in addition to vaccination to prevent infection. The “case‐case” case–control design provides a valuable method of calculating the effectiveness of this vaccine in travelers, given the availability of paratyphoid controls, a population with similar demographics and risk exposures. (Source: Journal of Travel Medicine)
Source: Journal of Travel Medicine - November 1, 2014 Category: Infectious Diseases Authors: Karen S. Wagner, Joanne L. Freedman, Nick J. Andrews, Jane A. Jones Tags: ORIGINAL ARTICLE Source Type: research
Point‐of‐Care Screening, Prevalence, and Risk Factors for Hepatitis B Infection Among 3,728 Mainly Undocumented Migrants From Non‐EU Countries in Northern Italy
ConclusionsOur results suggest that point‐of‐care screening is feasible in undocumented migrants and should be targeted according to provenance. Case detection of HBV infection among migrants could potentially reduce HBV incidence in migrants' contacts and in the general population by prompting vaccination of susceptible individuals and care of eligible infected patients. (Source: Journal of Travel Medicine)
Source: Journal of Travel Medicine - November 1, 2014 Category: Infectious Diseases Authors: Issa El‐Hamad, Maria Chiara Pezzoli, Erika Chiari, Carmelo Scarcella, Francesco Vassallo, Massimo Puoti, Anna Ciccaglione, Massimo Ciccozzi, Alfredo Scalzini, Francesco Castelli, Tags: ORIGINAL ARTICLE Source Type: research
Are Pharmacists Ready for a Greater Role in Travel Health? An Evaluation of the Knowledge and Confidence in Providing Travel Health Advice of Pharmacists Practicing in a Community Pharmacy Chain in Alberta, Canada
ConclusionsTravel health is becoming an increasingly common topic of discussion between patients and pharmacists. This study suggests that pharmacists' baseline knowledge of travel health may be incomplete, affecting their confidence in providing this advice. Undergraduate and continuing education training programs must expand travel health curricula to meet this growing need. (Source: Journal of Travel Medicine)
Source: Journal of Travel Medicine - November 1, 2014 Category: Infectious Diseases Authors: Christina S. Bascom, Meagen M. Rosenthal, Sherilyn K.D. Houle Tags: ORIGINAL ARTICLE Source Type: research
Airport Surveys at Travel Destinations—Underutilized Opportunities in Travel Medicine Research?
ConclusionsMillions of travelers in airports around the world represent an underutilized sample of potential study participants for topics that cannot be studied adequately in other settings. Benefiting from close cooperation between travel health professionals and airport authorities, researchers can expect not only large‐scale convenience samples for surveys, but also opportunities to explore exciting and creative research topics to broaden our understanding of travel medicine and health. (Source: Journal of Travel Medicine)
Source: Journal of Travel Medicine - November 1, 2014 Category: Infectious Diseases Authors: Irmgard L. Bauer Tags: REVIEW Source Type: research
Increasing Risks of Human Dirofilariasis in Travelers
ConclusionsTravel medicine clinicians must remain vigilant regarding the possibilities of human pulmonary dirofilariasis when solitary “coin lesions” appear on screening chest X‐rays or abdominal neuroimaging studies in asymptomatic patients without peripheral hypereosinophilia. The least invasive diagnostic methods are recommended. Future investigations should focus on conducting active epidemiological surveillance for dirofilariasis in humans and animals; on improving canine dirofilarial chemoprophylaxis; and on developing new, rapid molecular methods for diagnosing and differentiating human dirofilarial infections...
Source: Journal of Travel Medicine - November 1, 2014 Category: Infectious Diseases Authors: James H. Diaz Tags: REVIEW Source Type: research
Vaccine‐Preventable Travel Health Risks: What Is the Evidence—What Are the Gaps?
ConclusionsIn order for the WHO to produce graded risk statements in the updated version of “International Travel and Health,” major investment of time plus additional high‐quality, generalizable risk data are needed. (Source: Journal of Travel Medicine)
Source: Journal of Travel Medicine - November 1, 2014 Category: Infectious Diseases Authors: Robert Steffen, Ron H. Behrens, David R. Hill, Christina Greenaway, Karin Leder Tags: REVIEW Source Type: research
Response to Letter
(Source: Journal of Travel Medicine)
Source: Journal of Travel Medicine - October 27, 2014 Category: Infectious Diseases Authors: Liliana Praticò, Bianca Mariani, Enrico Brunetti, Roberta Maserati, Antonella Bruno, Stefano Novati, Guido Chichino Tags: CORRESPONDENCE Source Type: research
Follow‐Up of Treatment Response in Imported Acute Schistosomiasis
(Source: Journal of Travel Medicine)
Source: Journal of Travel Medicine - October 27, 2014 Category: Infectious Diseases Authors: Patrick Soentjens, Muriel Ruyffelaert, Audrey Collée, Sandrine Haverals, Alfons Van Gompel, Emmanuel Bottieau Tags: CORRESPONDENCE Source Type: research
Two Clusters of Ciguatera Fish Poisoning in Paris, France, Related to Tropical Fish Imported From the French Caribbean by Travelers
ConclusionsCFP may be seen in non‐traveler patients outside endemic countries resulting from imported species of fish. Thus, CFP may be undiagnosed as physicians are not aware of this tropical disease outside endemic countries. The detection of ciguatoxins by MBA in the French National Reference Laboratory is useful in the confirmation of the diagnosis. (Source: Journal of Travel Medicine)
Source: Journal of Travel Medicine - October 27, 2014 Category: Infectious Diseases Authors: Loïc Epelboin, Alice Pérignon, Virginie Hossen, Renaud Vincent, Sophie Krys, Eric Caumes Tags: ORIGINAL ARTICLE Source Type: research
Targeting of Rifamycin SV to the Colon for Treatment of Travelers' Diarrhea: A Randomized, Double‐Blind, Placebo‐Controlled Phase 3 Study
ConclusionsRIF‐MMX shortened the duration of TD in patients with a broad range of pathogens and was well tolerated. The unique pharmacokinetic properties of the drug offer evidence that TD pathogens work at the level of the colon. (Source: Journal of Travel Medicine)
Source: Journal of Travel Medicine - October 27, 2014 Category: Infectious Diseases Authors: Herbert L. DuPont, AnnKatrin Petersen, Jeff Zhao, Arley Mundt, Zhi‐Dong Jiang, Stephan Miller, Jose Flores, Reshma Shringarpure, Luigi Moro, Robert G. Bagin, E. David Ballard, Mark C. Totoritis Tags: ORIGINAL ARTICLE Source Type: research
Targeted Therapy in Travelers' Diarrhea: What Is the Role for the Non‐Absorbable?
(Source: Journal of Travel Medicine)
Source: Journal of Travel Medicine - October 27, 2014 Category: Infectious Diseases Authors: Mark S. Riddle, Bradley A. Connor, David R. Tribble Tags: EDITORIAL Source Type: research
Rabies Postexposure Consultations in New Zealand from 1998 to 2012
ConclusionsNew Zealanders require better guidance in understanding the need for travel‐related rabies vaccination, as they are not managed abroad according to WHO guidelines. Few travelers had had pre‐travel immunization, and only 20.3% of them had received WHO‐advised postexposure management. Thus, 79.7% of the cohort theoretically remained at risk for contracting rabies because of inappropriate management following possible exposure to the disease. (Source: Journal of Travel Medicine)
Source: Journal of Travel Medicine - October 15, 2014 Category: Infectious Diseases Authors: Marc T.M. Shaw, Jenny Visser, Ciaran Edwards Tags: ORIGINAL ARTICLE Source Type: research
Schistosomiasis in Pregnant Travelers: A Case Series
ConclusionThis is the first case‐series of pregnant travelers with schistosomiasis. Although a small case‐series with possible confounders, it suggests that schistosomiasis in pregnant travelers can be treated. A trend of lower birth weights was observed in the infants of the pregnant travelers who were not treated. PZQ therapy during pregnancy was not associated with adverse pregnancy or fetal outcomes in those four cases. Our results emphasize the importance of screening female travelers of childbearing age with a relevant history of freshwater exposure. Further studies are needed to reinforce these recommendations. ...
Source: Journal of Travel Medicine - October 13, 2014 Category: Infectious Diseases Authors: Eli Ben‐Chetrit, Tamar Lachish, Kristine Mørch, Drorit Atias, Conor Maguire, Eli Schwartz Tags: ORIGINAL ARTICLE Source Type: research
